nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.307	0.405	CbGaD
Fluoxymesterone—AR—type 2 diabetes mellitus	0.27	0.355	CbGaD
Fluoxymesterone—NR3C1—type 2 diabetes mellitus	0.183	0.241	CbGaD
Fluoxymesterone—SHBG—hindlimb—type 2 diabetes mellitus	0.0056	0.156	CbGeAlD
Fluoxymesterone—AR—penis—type 2 diabetes mellitus	0.00532	0.148	CbGeAlD
Fluoxymesterone—PRLR—cortex of kidney—type 2 diabetes mellitus	0.00526	0.146	CbGeAlD
Fluoxymesterone—Blood cholesterol increased—Rosiglitazone—type 2 diabetes mellitus	0.00514	0.0632	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Tolbutamide—type 2 diabetes mellitus	0.00342	0.042	CcSEcCtD
Fluoxymesterone—PRLR—liver—type 2 diabetes mellitus	0.00341	0.095	CbGeAlD
Fluoxymesterone—Jaundice cholestatic—Tolazamide—type 2 diabetes mellitus	0.00311	0.0382	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Chlorpropamide—type 2 diabetes mellitus	0.00311	0.0382	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Glipizide—type 2 diabetes mellitus	0.00206	0.0253	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Orlistat—type 2 diabetes mellitus	0.00205	0.0252	CcSEcCtD
Fluoxymesterone—Coagulopathy—Glyburide—type 2 diabetes mellitus	0.00179	0.022	CcSEcCtD
Fluoxymesterone—NR3C1—nerve—type 2 diabetes mellitus	0.00177	0.0492	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00164	0.0202	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Glyburide—type 2 diabetes mellitus	0.00159	0.0195	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Gliclazide—type 2 diabetes mellitus	0.00142	0.0175	CcSEcCtD
Fluoxymesterone—Libido decreased—Glipizide—type 2 diabetes mellitus	0.00142	0.0174	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Glipizide—type 2 diabetes mellitus	0.0013	0.016	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Orlistat—type 2 diabetes mellitus	0.00129	0.0159	CcSEcCtD
Fluoxymesterone—SHBG—cardiovascular system—type 2 diabetes mellitus	0.00119	0.0332	CbGeAlD
Fluoxymesterone—Jaundice cholestatic—Irbesartan—type 2 diabetes mellitus	0.00112	0.0138	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Bromocriptine—type 2 diabetes mellitus	0.0011	0.0135	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Losartan—type 2 diabetes mellitus	0.00106	0.013	CcSEcCtD
Fluoxymesterone—SHBG—adipose tissue—type 2 diabetes mellitus	0.00105	0.0292	CbGeAlD
Fluoxymesterone—Alopecia—Repaglinide—type 2 diabetes mellitus	0.000972	0.0119	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000964	0.0119	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Ramipril—type 2 diabetes mellitus	0.000908	0.0112	CcSEcCtD
Fluoxymesterone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000857	0.0238	CbGeAlD
Fluoxymesterone—AR—cardiovascular system—type 2 diabetes mellitus	0.000855	0.0238	CbGeAlD
Fluoxymesterone—ESR1—cardiovascular system—type 2 diabetes mellitus	0.00084	0.0234	CbGeAlD
Fluoxymesterone—AR—kidney—type 2 diabetes mellitus	0.000837	0.0233	CbGeAlD
Fluoxymesterone—ESR1—kidney—type 2 diabetes mellitus	0.000822	0.0229	CbGeAlD
Fluoxymesterone—AR—cortex of kidney—type 2 diabetes mellitus	0.000815	0.0227	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000781	0.0096	CcSEcCtD
Fluoxymesterone—AR—adipose tissue—type 2 diabetes mellitus	0.000754	0.021	CbGeAlD
Fluoxymesterone—ESR1—adipose tissue—type 2 diabetes mellitus	0.000741	0.0206	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000738	0.00908	CcSEcCtD
Fluoxymesterone—SHBG—liver—type 2 diabetes mellitus	0.000737	0.0205	CbGeAlD
Fluoxymesterone—Libido decreased—Losartan—type 2 diabetes mellitus	0.000728	0.00895	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.000714	0.00877	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00071	0.00873	CcSEcCtD
Fluoxymesterone—Nausea—Miglitol—type 2 diabetes mellitus	0.000707	0.0087	CcSEcCtD
Fluoxymesterone—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.000701	0.00862	CcSEcCtD
Fluoxymesterone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.00069	0.0192	CbGeAlD
Fluoxymesterone—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00069	0.00848	CcSEcCtD
Fluoxymesterone—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.000677	0.00832	CcSEcCtD
Fluoxymesterone—Anxiety—Glipizide—type 2 diabetes mellitus	0.000672	0.00826	CcSEcCtD
Fluoxymesterone—Headache—Tolbutamide—type 2 diabetes mellitus	0.000671	0.00825	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Losartan—type 2 diabetes mellitus	0.00067	0.00824	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000665	0.00818	CcSEcCtD
Fluoxymesterone—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000636	0.00782	CcSEcCtD
Fluoxymesterone—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000627	0.00771	CcSEcCtD
Fluoxymesterone—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.000625	0.00768	CcSEcCtD
Fluoxymesterone—Libido decreased—Ramipril—type 2 diabetes mellitus	0.000624	0.00768	CcSEcCtD
Fluoxymesterone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.00062	0.0172	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000619	0.00761	CcSEcCtD
Fluoxymesterone—Alopecia—Glyburide—type 2 diabetes mellitus	0.000619	0.00761	CcSEcCtD
Fluoxymesterone—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00061	0.0075	CcSEcCtD
Fluoxymesterone—Headache—Tolazamide—type 2 diabetes mellitus	0.00061	0.0075	CcSEcCtD
Fluoxymesterone—NR3C1—kidney—type 2 diabetes mellitus	0.000606	0.0169	CbGeAlD
Fluoxymesterone—Headache—Linagliptin—type 2 diabetes mellitus	0.000604	0.00743	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000603	0.00742	CcSEcCtD
Fluoxymesterone—NR3C1—pancreas—type 2 diabetes mellitus	0.000602	0.0168	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000601	0.00739	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.000598	0.00735	CcSEcCtD
Fluoxymesterone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.00059	0.0164	CbGeAlD
Fluoxymesterone—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000581	0.00714	CcSEcCtD
Fluoxymesterone—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00058	0.00714	CcSEcCtD
Fluoxymesterone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000579	0.00711	CcSEcCtD
Fluoxymesterone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000579	0.00711	CcSEcCtD
Fluoxymesterone—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000578	0.0071	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000576	0.00708	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Ramipril—type 2 diabetes mellitus	0.000574	0.00706	CcSEcCtD
Fluoxymesterone—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000574	0.00705	CcSEcCtD
Fluoxymesterone—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000571	0.00702	CcSEcCtD
Fluoxymesterone—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000566	0.00695	CcSEcCtD
Fluoxymesterone—Nausea—Acarbose—type 2 diabetes mellitus	0.000556	0.00684	CcSEcCtD
Fluoxymesterone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000546	0.0152	CbGeAlD
Fluoxymesterone—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000542	0.00666	CcSEcCtD
Fluoxymesterone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000536	0.00659	CcSEcCtD
Fluoxymesterone—AR—liver—type 2 diabetes mellitus	0.000529	0.0147	CbGeAlD
Fluoxymesterone—ESR1—liver—type 2 diabetes mellitus	0.000519	0.0144	CbGeAlD
Fluoxymesterone—Alopecia—Valsartan—type 2 diabetes mellitus	0.00051	0.00628	CcSEcCtD
Fluoxymesterone—Alopecia—Orlistat—type 2 diabetes mellitus	0.000504	0.0062	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.000503	0.0681	CrCbGaD
Fluoxymesterone—Headache—Repaglinide—type 2 diabetes mellitus	0.000489	0.00602	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000489	0.00601	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000476	0.00585	CcSEcCtD
Fluoxymesterone—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000464	0.00571	CcSEcCtD
Fluoxymesterone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000464	0.0057	CcSEcCtD
Fluoxymesterone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000463	0.00569	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000456	0.00561	CcSEcCtD
Fluoxymesterone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000447	0.00549	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000444	0.00546	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000443	0.00545	CcSEcCtD
Fluoxymesterone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000439	0.00539	CcSEcCtD
Fluoxymesterone—Stanozolol—AR—type 2 diabetes mellitus	0.000437	0.0592	CrCbGaD
Fluoxymesterone—Anxiety—Valsartan—type 2 diabetes mellitus	0.000427	0.00524	CcSEcCtD
Fluoxymesterone—Anxiety—Orlistat—type 2 diabetes mellitus	0.000422	0.00518	CcSEcCtD
Fluoxymesterone—Alopecia—Losartan—type 2 diabetes mellitus	0.000413	0.00508	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00041	0.00505	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000405	0.00499	CcSEcCtD
Fluoxymesterone—Headache—Glipizide—type 2 diabetes mellitus	0.000405	0.00498	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000401	0.00493	CcSEcCtD
Fluoxymesterone—Oxandrolone—AR—type 2 diabetes mellitus	0.000393	0.0533	CrCbGaD
Fluoxymesterone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000388	0.00477	CcSEcCtD
Fluoxymesterone—Nausea—Glipizide—type 2 diabetes mellitus	0.000384	0.00472	CcSEcCtD
Fluoxymesterone—NR3C1—liver—type 2 diabetes mellitus	0.000383	0.0107	CbGeAlD
Fluoxymesterone—Headache—Glimepiride—type 2 diabetes mellitus	0.000378	0.00465	CcSEcCtD
Fluoxymesterone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000377	0.00463	CcSEcCtD
Fluoxymesterone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000368	0.00453	CcSEcCtD
Fluoxymesterone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000367	0.00451	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000366	0.00451	CcSEcCtD
Fluoxymesterone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000364	0.00448	CcSEcCtD
Fluoxymesterone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000358	0.0044	CcSEcCtD
Fluoxymesterone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000357	0.00439	CcSEcCtD
Fluoxymesterone—Alopecia—Ramipril—type 2 diabetes mellitus	0.000354	0.00435	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000353	0.00434	CcSEcCtD
Fluoxymesterone—Anxiety—Losartan—type 2 diabetes mellitus	0.000345	0.00424	CcSEcCtD
Fluoxymesterone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000341	0.00419	CcSEcCtD
Fluoxymesterone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000336	0.00413	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000332	0.00408	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000329	0.00405	CcSEcCtD
Fluoxymesterone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00397	CcSEcCtD
Fluoxymesterone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000317	0.00389	CcSEcCtD
Fluoxymesterone—Headache—Glyburide—type 2 diabetes mellitus	0.000312	0.00383	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000302	0.00372	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000299	0.00367	CcSEcCtD
Fluoxymesterone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000298	0.00366	CcSEcCtD
Fluoxymesterone—Anxiety—Ramipril—type 2 diabetes mellitus	0.000296	0.00364	CcSEcCtD
Fluoxymesterone—Nausea—Glyburide—type 2 diabetes mellitus	0.000295	0.00363	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000285	0.0035	CcSEcCtD
Fluoxymesterone—Danazol—CCL2—type 2 diabetes mellitus	0.000283	0.0384	CrCbGaD
Fluoxymesterone—Headache—Gliclazide—type 2 diabetes mellitus	0.00028	0.00344	CcSEcCtD
Fluoxymesterone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000265	0.00326	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00026	0.00319	CcSEcCtD
Fluoxymesterone—Headache—Valsartan—type 2 diabetes mellitus	0.000257	0.00316	CcSEcCtD
Fluoxymesterone—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000256	0.00314	CcSEcCtD
Fluoxymesterone—Headache—Orlistat—type 2 diabetes mellitus	0.000254	0.00312	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000245	0.00301	CcSEcCtD
Fluoxymesterone—Nausea—Valsartan—type 2 diabetes mellitus	0.000244	0.003	CcSEcCtD
Fluoxymesterone—Nausea—Orlistat—type 2 diabetes mellitus	0.000241	0.00296	CcSEcCtD
Fluoxymesterone—Headache—Metformin—type 2 diabetes mellitus	0.000234	0.00288	CcSEcCtD
Fluoxymesterone—Nausea—Metformin—type 2 diabetes mellitus	0.000222	0.00273	CcSEcCtD
Fluoxymesterone—Headache—Irbesartan—type 2 diabetes mellitus	0.000221	0.00272	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00021	0.00258	CcSEcCtD
Fluoxymesterone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000209	0.00258	CcSEcCtD
Fluoxymesterone—Headache—Losartan—type 2 diabetes mellitus	0.000208	0.00256	CcSEcCtD
Fluoxymesterone—Nausea—Losartan—type 2 diabetes mellitus	0.000197	0.00242	CcSEcCtD
Fluoxymesterone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000184	0.0249	CrCbGaD
Fluoxymesterone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000182	0.0246	CrCbGaD
Fluoxymesterone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000179	0.0243	CrCbGaD
Fluoxymesterone—Headache—Ramipril—type 2 diabetes mellitus	0.000178	0.00219	CcSEcCtD
Fluoxymesterone—Nausea—Ramipril—type 2 diabetes mellitus	0.000169	0.00208	CcSEcCtD
Fluoxymesterone—Danazol—SHBG—type 2 diabetes mellitus	0.000161	0.0218	CrCbGaD
Fluoxymesterone—Testosterone Propionate—AR—type 2 diabetes mellitus	0.00016	0.0216	CrCbGaD
Fluoxymesterone—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000156	0.0211	CrCbGaD
Fluoxymesterone—Spironolactone—SHBG—type 2 diabetes mellitus	0.000154	0.0209	CrCbGaD
Fluoxymesterone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000153	0.0208	CrCbGaD
Fluoxymesterone—Megestrol acetate—NR3C1—type 2 diabetes mellitus	0.000148	0.02	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.000145	0.0196	CrCbGaD
Fluoxymesterone—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000145	0.0196	CrCbGaD
Fluoxymesterone—Norethindrone—SHBG—type 2 diabetes mellitus	0.000143	0.0194	CrCbGaD
Fluoxymesterone—Danazol—AR—type 2 diabetes mellitus	0.000141	0.0191	CrCbGaD
Fluoxymesterone—Mometasone—NR3C1—type 2 diabetes mellitus	0.000138	0.0186	CrCbGaD
Fluoxymesterone—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000136	0.0184	CrCbGaD
Fluoxymesterone—Spironolactone—AR—type 2 diabetes mellitus	0.000135	0.0183	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	0.000127	0.0172	CrCbGaD
Fluoxymesterone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000121	0.0164	CrCbGaD
Fluoxymesterone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000121	0.0164	CrCbGaD
Fluoxymesterone—Spironolactone—ABCC2—type 2 diabetes mellitus	0.00012	0.0163	CrCbGaD
Fluoxymesterone—Methyltestosterone—AR—type 2 diabetes mellitus	0.000119	0.0162	CrCbGaD
Fluoxymesterone—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000117	0.0159	CrCbGaD
Fluoxymesterone—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000112	0.0152	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000108	0.0147	CrCbGaD
Fluoxymesterone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000106	0.0144	CrCbGaD
Fluoxymesterone—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000103	0.0139	CrCbGaD
Fluoxymesterone—Triamcinolone—NR3C1—type 2 diabetes mellitus	9.54e-05	0.0129	CrCbGaD
Fluoxymesterone—Spironolactone—NR3C1—type 2 diabetes mellitus	9.18e-05	0.0124	CrCbGaD
Fluoxymesterone—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	9.02e-05	0.0122	CrCbGaD
Fluoxymesterone—Dexamethasone—NOS2—type 2 diabetes mellitus	8.99e-05	0.0122	CrCbGaD
Fluoxymesterone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	8.88e-05	0.012	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	8.6e-05	0.0117	CrCbGaD
Fluoxymesterone—Progesterone—SHBG—type 2 diabetes mellitus	8.35e-05	0.0113	CrCbGaD
Fluoxymesterone—Prednisolone—NR3C1—type 2 diabetes mellitus	7.97e-05	0.0108	CrCbGaD
Fluoxymesterone—Testosterone—SHBG—type 2 diabetes mellitus	7.9e-05	0.0107	CrCbGaD
Fluoxymesterone—Betamethasone—NR3C1—type 2 diabetes mellitus	7.81e-05	0.0106	CrCbGaD
Fluoxymesterone—Eplerenone—CYP3A4—type 2 diabetes mellitus	7.8e-05	0.0106	CrCbGaD
Fluoxymesterone—Progesterone—AR—type 2 diabetes mellitus	7.33e-05	0.00992	CrCbGaD
Fluoxymesterone—Testosterone—AR—type 2 diabetes mellitus	6.93e-05	0.00938	CrCbGaD
Fluoxymesterone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	6.78e-05	0.00919	CrCbGaD
Fluoxymesterone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	6.1e-05	0.00826	CrCbGaD
Fluoxymesterone—Dexamethasone—ABCC2—type 2 diabetes mellitus	5.96e-05	0.00807	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	5.79e-05	0.000501	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOB—type 2 diabetes mellitus	5.69e-05	0.000493	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.67e-05	0.000491	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.6e-05	0.000485	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	5.58e-05	0.000483	CbGpPWpGaD
Fluoxymesterone—Danazol—CYP3A4—type 2 diabetes mellitus	5.55e-05	0.00753	CrCbGaD
Fluoxymesterone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.53e-05	0.00749	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	5.48e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	5.48e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT2—type 2 diabetes mellitus	5.46e-05	0.000472	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LPL—type 2 diabetes mellitus	5.44e-05	0.00047	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.41e-05	0.00733	CrCbGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	5.4e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	5.34e-05	0.000462	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.32e-05	0.00046	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	5.29e-05	0.000458	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3R1—type 2 diabetes mellitus	5.28e-05	0.000457	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—type 2 diabetes mellitus	5.26e-05	0.000455	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	5.15e-05	0.000446	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	5.13e-05	0.000444	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.1e-05	0.000441	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2—type 2 diabetes mellitus	5.09e-05	0.00044	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	5.07e-05	0.000439	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	5.03e-05	0.000435	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.01e-05	0.000433	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	5e-05	0.000432	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	4.99e-05	0.00676	CrCbGaD
Fluoxymesterone—PRLR—Immune System—RELA—type 2 diabetes mellitus	4.97e-05	0.00043	CbGpPWpGaD
Fluoxymesterone—Progesterone—NR3C1—type 2 diabetes mellitus	4.97e-05	0.00673	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3R1—type 2 diabetes mellitus	4.95e-05	0.000428	CbGpPWpGaD
Fluoxymesterone—Norethindrone—CYP3A4—type 2 diabetes mellitus	4.94e-05	0.0067	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—C3—type 2 diabetes mellitus	4.9e-05	0.000423	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	4.9e-05	0.000423	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.89e-05	0.000423	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	4.79e-05	0.000414	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	4.71e-05	0.000407	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	4.69e-05	0.00636	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.67e-05	0.000404	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.66e-05	0.000403	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.65e-05	0.000403	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGT—type 2 diabetes mellitus	4.65e-05	0.000402	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	4.64e-05	0.000401	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	4.63e-05	0.000401	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	4.63e-05	0.0004	CbGpPWpGaD
Fluoxymesterone—Prednisolone—CYP3A4—type 2 diabetes mellitus	4.62e-05	0.00626	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	4.59e-05	0.000397	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.57e-05	0.000396	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—type 2 diabetes mellitus	4.56e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—type 2 diabetes mellitus	4.56e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	4.55e-05	0.000393	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.55e-05	0.000393	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	4.54e-05	0.000393	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.54e-05	0.00616	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.53e-05	0.000392	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	4.53e-05	0.000392	CbGpPWpGaD
Fluoxymesterone—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.53e-05	0.00613	CrCbGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	4.52e-05	0.000391	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.51e-05	0.00039	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—type 2 diabetes mellitus	4.43e-05	0.00601	CrCbGaD
Fluoxymesterone—Progesterone—CYP1A2—type 2 diabetes mellitus	4.35e-05	0.00589	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—type 2 diabetes mellitus	4.33e-05	0.000375	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ALB—type 2 diabetes mellitus	4.31e-05	0.00584	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.3e-05	0.000372	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.25e-05	0.000368	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	4.22e-05	0.000365	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NFKB1—type 2 diabetes mellitus	4.19e-05	0.000363	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	4.19e-05	0.000362	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	4.18e-05	0.00567	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—type 2 diabetes mellitus	4.09e-05	0.00555	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.08e-05	0.000353	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.07e-05	0.000352	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.05e-05	0.000351	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.01e-05	0.000347	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—type 2 diabetes mellitus	4e-05	0.000346	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	3.99e-05	0.000345	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	3.98e-05	0.000344	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.97e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.96e-05	0.000342	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.95e-05	0.000342	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—type 2 diabetes mellitus	3.91e-05	0.000338	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—type 2 diabetes mellitus	3.89e-05	0.000337	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.89e-05	0.000336	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.88e-05	0.000335	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.86e-05	0.000334	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.83e-05	0.000331	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.82e-05	0.00033	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.8e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.79e-05	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	3.77e-05	0.000326	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.77e-05	0.000326	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.76e-05	0.000326	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.76e-05	0.000326	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.74e-05	0.000324	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.71e-05	0.000321	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.67e-05	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	3.67e-05	0.000317	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.65e-05	0.000316	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.59e-05	0.00031	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.58e-05	0.000309	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.54e-05	0.000306	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.54e-05	0.00479	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.5e-05	0.000303	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.5e-05	0.000303	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.47e-05	0.0003	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.45e-05	0.000298	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.44e-05	0.000298	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	3.43e-05	0.000297	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—type 2 diabetes mellitus	3.42e-05	0.000296	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.41e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.41e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.41e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.31e-05	0.000286	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.27e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	3.23e-05	0.000279	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RELA—type 2 diabetes mellitus	3.21e-05	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—type 2 diabetes mellitus	3.21e-05	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	3.17e-05	0.000274	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	3.14e-05	0.000271	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	3.09e-05	0.000267	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	3.07e-05	0.000266	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.05e-05	0.000264	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	3e-05	0.000259	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	3e-05	0.000259	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.97e-05	0.000257	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.97e-05	0.000257	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.95e-05	0.000255	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CTGF—type 2 diabetes mellitus	2.94e-05	0.000254	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.91e-05	0.000252	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.91e-05	0.000252	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.9e-05	0.000251	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.88e-05	0.000249	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP3A4—type 2 diabetes mellitus	2.88e-05	0.0039	CrCbGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.84e-05	0.000245	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.79e-05	0.000241	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.75e-05	0.000238	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.74e-05	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.73e-05	0.000236	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP3A4—type 2 diabetes mellitus	2.72e-05	0.00369	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.71e-05	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.67e-05	0.000231	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.66e-05	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.64e-05	0.000228	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.00357	CrCbGaD
Fluoxymesterone—PRLR—Immune System—IL6—type 2 diabetes mellitus	2.63e-05	0.000228	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.6e-05	0.000225	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.58e-05	0.00349	CrCbGaD
Fluoxymesterone—ESR1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.56e-05	0.000222	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.55e-05	0.00022	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.55e-05	0.00022	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.53e-05	0.000218	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—type 2 diabetes mellitus	2.47e-05	0.000213	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.46e-05	0.000213	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.46e-05	0.000213	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.44e-05	0.000211	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—type 2 diabetes mellitus	2.43e-05	0.00021	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.38e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—type 2 diabetes mellitus	2.37e-05	0.00322	CrCbGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.35e-05	0.000203	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.33e-05	0.000201	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.31e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.31e-05	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.29e-05	0.000198	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—type 2 diabetes mellitus	2.28e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.27e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.27e-05	0.000197	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CTGF—type 2 diabetes mellitus	2.27e-05	0.000196	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.27e-05	0.000196	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.26e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.23e-05	0.000193	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.21e-05	0.000191	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	2.19e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.18e-05	0.000189	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	2.17e-05	0.000187	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.15e-05	0.000186	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.11e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.11e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.96e-05	0.00017	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.94e-05	0.000168	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.93e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.93e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.93e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	1.92e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.91e-05	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.9e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.88e-05	0.000162	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.88e-05	0.000162	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.85e-05	0.00016	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AR—type 2 diabetes mellitus	1.83e-05	0.000158	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.8e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARA—type 2 diabetes mellitus	1.8e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.69e-05	0.000146	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.67e-05	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.67e-05	0.000144	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.66e-05	0.000144	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.66e-05	0.000144	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.65e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.64e-05	0.000142	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.62e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.61e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.55e-05	0.000134	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.5e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.5e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—type 2 diabetes mellitus	1.49e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	1.48e-05	0.000128	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.47e-05	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.46e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.45e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.45e-05	0.000126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.43e-05	0.000124	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.42e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.42e-05	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.41e-05	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	1.39e-05	0.00012	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.37e-05	0.000118	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.34e-05	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.32e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.3e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.3e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.28e-05	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.28e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	1.15e-05	9.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.13e-05	9.79e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.13e-05	9.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.12e-05	9.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.11e-05	9.57e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.11e-05	9.57e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.1e-05	9.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.1e-05	9.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.07e-05	9.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.06e-05	9.21e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.05e-05	9.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.03e-05	8.93e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.02e-05	8.83e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.02e-05	8.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1e-05	8.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.58e-06	8.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.41e-06	8.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	9.19e-06	7.95e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.77e-06	7.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.75e-06	7.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.73e-06	7.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.59e-06	7.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.56e-06	7.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.56e-06	7.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.46e-06	7.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.07e-06	6.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.63e-06	6.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	7.31e-06	6.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.19e-06	6.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.07e-06	6.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.07e-06	6.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.72e-06	5.81e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.41e-06	5.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.41e-06	5.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.04e-06	5.22e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—type 2 diabetes mellitus	5.88e-06	5.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.44e-06	4.71e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.14e-06	4.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.09e-06	4.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.74e-06	4.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.62e-06	4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	4.53e-06	3.92e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	4.46e-06	3.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.24e-06	3.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.16e-06	3.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-06	2.76e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.95e-06	2.55e-05	CbGpPWpGaD
